# Aktis Oncology: Biotechnology, Boston, United States

> Aktis Oncology: Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.

Source: https://millionrounds.com/startup/aktis-oncology (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# Aktis Oncology

Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.

Funding reported Last round: Corporate round

Biotechnology Boston, United States

Company summary

- **Founded:** 2021 5 years old
- **Team:** 11 11 to 50 people
- **Funding reported:** $175M in dollars
- **Last round:** Corporate round May 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Aktis Oncology has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Aktis Oncology raised

Funding, as reported

Reported in all **$175M** in dollars

Rounds **3**

Last round **Corporate round**

Last round date **May 2024**

Investors listed **15**

SEC Form D **$175M sold, 1 filing, last Oct 2024**

## Founders and team

From Aktis Oncology's own website: 1 founder, 9 on the team.

**Todd Foley** Co-founder and Chairman

- **Dana Kennedy** Senior Vice President
- **Kyle Kuvalanka** Chief Financial Officer
- **Mary Thistle** Independent Director
- **Mike Sherman** Independent Director
- **Carlos Rodriguez** Team
- **Karen McCarthy** Team
- **Lorraine Horgan** Team
- **Nate Demars** Team
- **Timothy I. Mitchell** Team

## On 6 portfolio pages

Investors who name them

- [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital)
- [MPM Capital](https://millionrounds.com/fund/mpm-bioimpact)
- [TCG Crossover](https://millionrounds.com/fund/tcg-crossover)
- [Vida Ventures](https://millionrounds.com/fund/vida-ventures-llc)
- [Paratus Investment](https://millionrounds.com/fund/paratus-investment-inc)
- [Mirae Asset Capital Life Science](https://millionrounds.com/fund/mirae-asset-capital-life-science)

Each firm lists Aktis Oncology on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biotechnology in United States

Startups like it

- [**Sojournix** Waltham · founded 2016 *Raised*](https://millionrounds.com/company/sojournix)
- [**Receptor Life Sciences** Seattle · founded 2017 *Raised*](https://millionrounds.com/company/receptor-life-sciences)
- [**Attune Pharmaceuticals** New York · founded 2018 *Raised*](https://millionrounds.com/company/attune-pharmaceuticals)
- [**AbbVie** North Chicago · founded 2012](https://millionrounds.com/startup/abbvie-2)
- [**Grail** Menlo Park · founded 2015](https://millionrounds.com/startup/grail-3)
- [**EQRx** Cambridge · founded 2019](https://millionrounds.com/startup/eqrx)
- [**Cerevel Therapeutics** Boston · founded 2018](https://millionrounds.com/startup/cerevel-therapeutics)
- [**Royalty Pharma** New York · founded 1996](https://millionrounds.com/startup/royalty-pharma)

## Is this your company?

Add your raise, your deck and your story, and put Aktis Oncology in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)